Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses-Reference-Cited by-同舟云学术

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

Published:2014-01-23 Issue:1 Volume:7 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Coiffier Bertrand,Pro Barbara,Prince H Miles,Foss Francine,Sokol Lubomir,Greenwood Matthew,Caballero Dolores,Morschhauser Franck,Wilhelm Martin,Pinter-Brown Lauren,Padmanabhan Iyer Swaminathan,Shustov Andrei,Nielsen Tina,Nichols Jean,Wolfson Julie,Balser Barbara,Horwitz Steven

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/1756-8722-7-11.pdf

Reference33 articles.

1. Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K: Peripheral T-cell lymphoma. Blood. 2011, 117 (25): 6756-6767. 10.1182/blood-2010-05-231548.

2. Vose J, Armitage J, Weisenburger D, International T-Cell Lymphoma Project: International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008, 26 (25): 4124-4130.

3. Horwitz SM: Management of peripheral T-cell non-Hodgkin's lymphoma. Curr Opin Oncol. 2007, 19 (5): 438-443. 10.1097/CCO.0b013e3282ce6f8f.

4. Ascani S, Zinzani PL, Gherlinzoni F, Sabattini E, Briskomatis A, de Vivo A, Piccioli M, Fraternali Orcioni G, Pieri F, Goldoni A: Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification. Ann Oncol. 1997, 8 (6): 583-592. 10.1023/A:1008200307625.

5. Anderson JR, Armitage JO, Weisenburger DD: Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998, 9 (7): 717-720. 10.1023/A:1008265532487.

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

2. Discovery of molecularly-informed therapeutic strategies for mature T-cell neoplasms;2024-06-13

3. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma;Leukemia & Lymphoma;2024-03-22

4. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

5. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study;Clinical Cancer Research;2024-01-08